Literature DB >> 7746239

Assessment and management of opioid withdrawal in ill neonates.

L Franck, J Vilardi.   

Abstract

Neonatal physical dependence on opioids occurs in two ways: (1) through passive exposure in utero from maternal ingestion of drugs such as heroin or methadone or (2) through the administration of opioids such as morphine, fentanyl, or methadone for analgesia and sedation in the NICU. This article provides a comprehensive review of the mechanisms of opioid tolerance, physical dependence, and withdrawal specific to the neonate. Particular emphasis is given to the assessment of iatrogenic neonatal abstinence syndrome in the ill neonate and to its prevention and management in the NICU.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746239

Source DB:  PubMed          Journal:  Neonatal Netw        ISSN: 0730-0832


  10 in total

1.  The effects of buprenorphine on fentanyl withdrawal in rats.

Authors:  Adrie W Bruijnzeel; Catherine Marcinkiewcz; Shani Isaac; Matthew M Booth; Donn M Dennis; Mark S Gold
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

2.  Hyperphagia in neonates withdrawing from methadone.

Authors:  A Martinez; B Kastner; H W Taeusch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

3.  Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.

Authors:  M H Zissen; G Zhang; A McKelvy; J T Propst; J J Kendig; S M Sweitzer
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

Review 4.  Current guidelines for the treatment of acute pain in children.

Authors:  V Bhatt-Mehta
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

5.  Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse.

Authors:  B Bar-Oz; J Klein; T Karaskov; G Koren
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

Review 6.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

7.  Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol.

Authors:  Melissa R Johnson; David R Nash; Mary R Laird; Robert C Kiley; Michael A Martinez
Journal:  J Pediatr Pharmacol Ther       Date:  2014-07

Review 8.  Tolerance and withdrawal from prolonged opioid use in critically ill children.

Authors:  Kanwaljeet J S Anand; Douglas F Willson; John Berger; Rick Harrison; Kathleen L Meert; Jerry Zimmerman; Joseph Carcillo; Christopher J L Newth; Parthak Prodhan; J Michael Dean; Carol Nicholson
Journal:  Pediatrics       Date:  2010-04-19       Impact factor: 7.124

9.  Practice guidelines for sedation and analgesia management of critically ill children: a pilot study evaluating guideline impact and feasibility in the PICU.

Authors:  Samantha J Keogh; Debbie A Long; Desley V Horn
Journal:  BMJ Open       Date:  2015-03-30       Impact factor: 2.692

10.  Morphine treatment alters nucleotidase activities in rat blood serum.

Authors:  Joanna Ripoll Rozisky; Yasmine Nonose; Gabriela Laste; Vinicius Souza Dos Santos; Isabel Cristina de Macedo; Ana Maria Oliveira Battastini; Wolnei Caumo; Iraci Ls Torres
Journal:  J Exp Pharmacol       Date:  2012-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.